$160,000 of SAREPTA THERAPEUTICS INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 9260 - LHHS Appropriations Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to Section 232"
You can find more data on corporate lobbying on Quiver Quantitative.
SRPT Hedge Fund Activity
We have seen 135 institutional investors add shares of SRPT stock to their portfolio, and 176 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 4,239,681 shares (+28.7%) to their portfolio in Q2 2026, for an estimated $76,187,067
- RA CAPITAL MANAGEMENT, L.P. removed 3,902,596 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $70,129,650
- AQR CAPITAL MANAGEMENT LLC removed 2,107,423 shares (-32.8%) from their portfolio in Q2 2026, for an estimated $37,870,391
- D. E. SHAW & CO., INC. removed 1,540,390 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $27,680,808
- MARSHALL WACE, LLP added 1,480,954 shares (+204.3%) to their portfolio in Q2 2026, for an estimated $26,612,743
- CANADA PENSION PLAN INVESTMENT BOARD removed 1,172,000 shares (-94.3%) from their portfolio in Q2 2026, for an estimated $21,060,840
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 980,321 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,616,368
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
SRPT Price Targets
Multiple analysts have issued price targets for $SRPT recently. We have seen 2 analysts offer price targets for $SRPT in the last 6 months, with a median target of $23.5.
Here are some recent targets:
- Andy Chen from Wolfe Research set a target price of $27.0 on 07/09/2026
- Biren Amin from Piper Sandler set a target price of $20.0 on 07/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
